FindTrial
Sign In

Uso del Nabilone nel trattamento del dolore cronico in pazienti con MOH non rispondenti ad altri trattamenti - ND

Uso del Nabilone nel trattamento del dolore cronico in pazienti con MOH non rispondenti ad altri trattamenti - ND

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2007-007873-22-IT
Enrollment
Unknown
Registered
2007-12-20
Start date
2009-02-10
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pazienti con cefalea cronica quotidiana MedDRA version: 9.1 Level: LLT Classification code 10019211 Term: Headache

Interventions

Product Name: Nabilone Pharmaceutical Form: Capsule, hard INN or Proposed INN: Nabilone Concentration unit: mg milligram(s) Concentration type: equal Concentration number: .5- Product Name: Ibuprofen

Sponsors

AZIENDA OSPEDALIERA POLICLINICO DI MODENA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Cefalea cronica quotidiana Abuso di analgesici Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Indice emicranico inferiore a 15 attacchia la mese consumo di analgesici inferiore a 10 al mese

Design outcomes

Primary

MeasureTime frame
Main Objective: Valutare la sicurezza e la tollerabilita' del farmaco;Secondary Objective: Riduzione del consumo di analgesici;Primary end point(s): Valutare la sicurezza e la tollerabilita' del farmaco—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026